Company intelligence / Profile preview

Wuhan Keqian Biology

Ownership: Private
Employees: ~924
Development stage: Commercial

Overview

Wuhan Keqian Biology is a leading Chinese developer and manufacturer of veterinary vaccines and diagnostic reagents for pigs, poultry, and pets. The company operates GMP-certified facilities and has a strong R&D team with numerous patents and new drug certifications. Its products are widely used by large farming groups across China[1][2][3][4][5].

Therapeutic areas: Infectious Diseases
Modalities: VaccineDiagnostic reagent
Industry: Veterinary

Partnerships

Strong technical support from State Key Laboratory of Agricultural Microbiology and Huazhong Agricultural University

Beyond the preview

Go deeper on Wuhan Keqian Biology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wuhan Keqian Biology.

Explore the full profile